期刊文献+

规范朱砂、雄黄及相关成方制剂标准的思考 被引量:4

Considerations on the Normalization Standard of Cinnabaris,Realgar and Related Chinese Medicine Set Prescription Drug Agents
下载PDF
导出
摘要 朱砂和雄黄在我国临床应用历史非常悠久,至今应用十分广泛,尤其是我国现行上市的中成药中,含有朱砂和雄黄的品种很多,如安宫牛黄丸、牛黄清心丸等等。而且,近年来雄黄在中医以毒攻毒理论指导下,还成功用于白血病的治疗。但是,随之临床应用的普及和推广,不良反应也日益增多,引起了国内外的广泛关注。如何安全、有效、合理的使用朱砂、雄黄以及含有朱砂、雄黄的中成药,规范其使用标准已是当前必须亟待解决的严重问题。本文分析朱砂、雄黄产生不良反应的原因,并指出需要对朱砂、雄黄在成药中药用价值进行再评定,且针对朱砂、雄黄存在的问题,提出了相应的对策。 Cinnabaris and Realgar have a long history of clinical application, and until now they are still widely used. There are many kinds of Proprietary Chinese Medicines which contain Cinnabaris and Realgar such as "An gong niu huang wan" ," Niu huang qing xin wan" and so on. And now Realgar has been successfully used on the leueoeythemia treatment which has been under the guidance of tra- ditional Chinese medicine theory of "fight fire with fire". But followed with the spread use on clinical application, it also accompanies with an increasing number of adverse reactions. This has caused people both at home and abroad to pay great attention. It seemed that how to safely, effectively and properly use Cinnabaris, Realgar and Proprietary Chinese Medicines which contain Cinnabaris and Realgar, to regulate the use of standard of them have became our serious problems in urgent need of solutions. This paper analyzes the ad- verse reactions that caused by Cinnabaris and Realgar, and also points out that we need to revalue Cinnabaris and Realgar in Proprieta- ry Chinese Medicines, and also suggest some countermeasures to aim directly at problems.
机构地区 北京中医药大学
出处 《中国药品标准》 CAS 2009年第4期256-258,共3页 Drug Standards of China
关键词 朱砂 雄黄 相关成方制剂 不良反应 对策 Cinnabaris Realgar related Chinese medicine set prescription drug agents adverse reaction countermeasures
  • 相关文献

参考文献7

二级参考文献13

共引文献94

同被引文献64

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部